Vapreotide is only found in individuals that have used or taken this drug. It is a synthetic octapeptide somatostatin analog. It was being studied for the treatment of cancer.The exact mechanism of action is unknown, although one study has provided in vitro and in vivo evidence for a tachykinin NK1 receptor antagonist effect in the analgesic effects of vapreotide. The directory classifies it as a clinical API with a peptide source/manufacturing origin. Other names for this substance include Octastatin and Docrised. Its PubChem CID is 6918025.
Vapreotide acetate
| CAS No | 116430-60-5 |
|---|---|
| Molecular Formula | C59H74N12O11S2 |
| Molecular Weight | 1191.4 g/mol |
| Synonyms | acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Vapreotide is only found in individuals that have used or taken this drug. It is a synthetic octapeptide somatostatin analog. The exact mechanism of action is unknown, although one study has provided in vitro and in vivo evidence for a tachykinin NK1 receptor antagonist effect in the analgesic effects of vapreotide.
The listed CAS number is 116430-60-5.
The listed molecular formula is C59H74N12O11S2.
The listed molecular weight is 1191.4 g/mol.
acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide.
The source lists Octastatin and Docrised.